Anti-MDA5 associated clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease

Anti-melanoma differentiation-associated protein 5 (anti-MDA5) associated clinically amyopathic dermatomyositis (CADM) is a rare entity that is frequently associated with rapidly progressive interstitial lung disease.